155 related articles for article (PubMed ID: 2447652)
1. IgG from patients with Lambert-Eaton syndrome blocks voltage-dependent calcium channels.
Kim YI; Neher E
Science; 1988 Jan; 239(4838):405-8. PubMed ID: 2447652
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of calcium currents and exocytosis by Lambert-Eaton syndrome antibodies in human lung cancer cells.
Viglione MP; O'Shaughnessy TJ; Kim YI
J Physiol; 1995 Oct; 488 ( Pt 2)(Pt 2):303-17. PubMed ID: 8568672
[TBL] [Abstract][Full Text] [Related]
3. Antibodies against calcium channels in the Lambert-Eaton myasthenic syndrome.
Wray DW; Lang B; Newsom-Davis J; Peers C
Ann N Y Acad Sci; 1989; 560():269-77. PubMed ID: 2545139
[No Abstract] [Full Text] [Related]
4. Lambert-Eaton syndrome antibodies inhibit acetylcholine release and P/Q-type Ca2+ channels in electric ray nerve endings.
Satoh Y; Hirashima N; Tokumaru H; Takahashi MP; Kang J; Viglione MP; Kim YI; Kirino Y
J Physiol; 1998 Apr; 508 ( Pt 2)(Pt 2):427-38. PubMed ID: 9508807
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of voltage-gated calcium channels in small cell carcinomas of patients with and without Lambert-Eaton myasthenic syndrome by autoantibodies omega-conotoxin and adenosine.
De Aizpurua HJ; Lambert EH; Griesmann GE; Olivera BM; Lennon VA
Cancer Res; 1988 Sep; 48(17):4719-24. PubMed ID: 2457429
[TBL] [Abstract][Full Text] [Related]
6. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line.
Roberts A; Perera S; Lang B; Vincent A; Newsom-Davis J
Nature; 1985 Oct 24-30; 317(6039):737-9. PubMed ID: 2414666
[TBL] [Abstract][Full Text] [Related]
8. Interference with calcium channels by Lambert Eaton myasthenic syndrome antibody.
Wray DW; Peers C; Lang B; Lande S; Newsom-Davis J
Ann N Y Acad Sci; 1987; 505():368-76. PubMed ID: 2446554
[No Abstract] [Full Text] [Related]
9. Lambert-Eaton myasthenic syndrome: a review.
Newsom-Davis J
Monogr Allergy; 1988; 25():116-24. PubMed ID: 2845259
[TBL] [Abstract][Full Text] [Related]
10. Lambert-Eaton myasthenic syndrome IgG depletes presynaptic membrane active zone particles by antigenic modulation.
Nagel A; Engel AG; Lang B; Newsom-Davis J; Fukuoka T
Ann Neurol; 1988 Oct; 24(4):552-8. PubMed ID: 2853605
[TBL] [Abstract][Full Text] [Related]
11. Lambert-Eaton myasthenic syndrome: evidence for calcium channel blockade.
Kim YI
Ann N Y Acad Sci; 1987; 505():377-9. PubMed ID: 2446555
[No Abstract] [Full Text] [Related]
12. Increased frequency of IgG heavy chain marker Glm(2) and of HLA-B8 in Lambert-Eaton myasthenic syndrome with and without associated lung carcinoma.
Willcox N; Demaine AG; Newsom-Davis J; Welsh KI; Robb SA; Spiro SG
Hum Immunol; 1985 Sep; 14(1):29-36. PubMed ID: 2993207
[TBL] [Abstract][Full Text] [Related]
13. Lambert-Eaton syndrome antibodies: reaction with membranes from a small cell lung cancer xenograft.
Chester KA; Lang B; Gill J; Vincent A; Newsom-Davis J
J Neuroimmunol; 1988 May; 18(2):97-104. PubMed ID: 2833535
[TBL] [Abstract][Full Text] [Related]
14. Voltage-dependent Ca2+ channels in small cell carcinomas are blocked by autoantibodies from patients with Lambert-Eaton myasthenic syndrome.
De Aizpurua HJ; Griesmann GE; Lambert EH; Lennon VA
Ann N Y Acad Sci; 1988; 540():369-71. PubMed ID: 2849894
[No Abstract] [Full Text] [Related]
15. Specificity of Lambert-Eaton myasthenic syndrome immunoglobulin for nerve terminal calcium channels.
Hewett SJ; Atchison WD
Brain Res; 1992 Dec; 599(2):324-32. PubMed ID: 1363289
[TBL] [Abstract][Full Text] [Related]
16. Lambert-Eaton myasthenic syndrome: immunoglobulin G inhibition of Ca2+ flux in tumor cells correlates with disease severity.
Lang B; Vincent A; Murray NM; Newsom-Davis J
Ann Neurol; 1989 Mar; 25(3):265-71. PubMed ID: 2543262
[TBL] [Abstract][Full Text] [Related]
17. Motor nerve terminal calcium channels in Lambert-Eaton myasthenic syndrome. Morphologic evidence for depletion and that the depletion is mediated by autoantibodies.
Engel AG; Nagel A; Fukuoka T; Fukunaga H; Osame M; Lang B; Newsom-Davis J; Vincent A; Wray DW; Peers C
Ann N Y Acad Sci; 1989; 560():278-90. PubMed ID: 2545141
[No Abstract] [Full Text] [Related]
18. Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma.
Meriney SD; Hulsizer SC; Lennon VA; Grinnell AD
Ann Neurol; 1996 Nov; 40(5):739-49. PubMed ID: 8957015
[TBL] [Abstract][Full Text] [Related]
19. Effects of Lambert-Eaton syndrome serum and IgG on calcium and sodium currents in small-cell lung cancer cells.
Viglione MP; Blandino JK; Kim SJ; Kim YI
Ann N Y Acad Sci; 1993 Jun; 681():418-21. PubMed ID: 8395159
[No Abstract] [Full Text] [Related]
20. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
